156 related articles for article (PubMed ID: 38760939)
41. Fibronectin-mediated adhesion of fibroblasts: inhibition by dermatan sulfate proteoglycan and evidence for a cryptic glycosaminoglycan-binding domain.
Lewandowska K; Choi HU; Rosenberg LC; Zardi L; Culp LA
J Cell Biol; 1987 Sep; 105(3):1443-54. PubMed ID: 2958485
[TBL] [Abstract][Full Text] [Related]
42. Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis.
Lin HY; Lo YT; Wang TJ; Huang SF; Tu RY; Chen TL; Lin SP; Chuang CK
Sci Rep; 2019 Jul; 9(1):10755. PubMed ID: 31341247
[TBL] [Abstract][Full Text] [Related]
43. Heparan sulfate and dermatan sulfate from the liver of a patient with Hurler syndrome: high performance liquid chromatography of their degradation products after incubation with alpha-L-iduronidase-deficient fibroblasts.
Minami R; Fujibayashi S; Igarashi C; Ishikawa Y; Wagatsuma K; Nakao T; Tsugawa S
Clin Chim Acta; 1984 Feb; 137(2):179-87. PubMed ID: 6231139
[TBL] [Abstract][Full Text] [Related]
44. Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement.
Hampe CS; Wesley J; Lund TC; Orchard PJ; Polgreen LE; Eisengart JB; McLoon LK; Cureoglu S; Schachern P; McIvor RS
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572941
[TBL] [Abstract][Full Text] [Related]
45. Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I.
Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; de Carvalho TG; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Sakura N; Barrera L; Kida K; Kubota M; Orii T
J Inherit Metab Dis; 2010 Apr; 33(2):141-50. PubMed ID: 20162367
[TBL] [Abstract][Full Text] [Related]
46. Qualitative and quantitative analyses in sulfated glycosaminoglycans, chondroitin sulfate/dermatan sulfate, during 3 T3-L1 adipocytes differentiation.
Cahyadi DD; Warita K; Takeda-Okuda N; Tamura JI; Hosaka YZ
Anim Sci J; 2023; 94(1):e13894. PubMed ID: 38054387
[TBL] [Abstract][Full Text] [Related]
47. Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients.
Bhalla A; Ravi R; Fang M; Arguello A; Davis SS; Chiu CL; Blumenfeld JR; Nguyen HN; Earr TK; Wang J; Astarita G; Zhu Y; Fiore D; Scearce-Levie K; Diaz D; Cahan H; Troyer MD; Harris JM; Escolar ML
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707880
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS.
Tanaka N; Kida S; Kinoshita M; Morimoto H; Shibasaki T; Tachibana K; Yamamoto R
Mol Genet Metab; 2018 Sep; 125(1-2):53-58. PubMed ID: 30064964
[TBL] [Abstract][Full Text] [Related]
49. Reduction of lysosome abundance and GAG accumulation after odiparcil treatment in MPS I and MPS VI models.
Tuyaa-Boustugue P; Jantzen I; Zhang H; Young SP; Broqua P; Tallandier M; Entchev E
Mol Genet Metab Rep; 2023 Dec; 37():101011. PubMed ID: 38053941
[TBL] [Abstract][Full Text] [Related]
50. Tilorone-induced lysosomal storage of glycosaminoglycans in cultured corneal fibroblasts: biochemical and physicochemical investigations.
Fischer J
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):215-22. PubMed ID: 7492315
[TBL] [Abstract][Full Text] [Related]
51. The levels of urinary glycosaminoglycans of patients with attenuated and severe type of mucopolysaccharidosis II determined by liquid chromatography-tandem mass spectrometry.
Mashima R; Sakai E; Tanaka M; Kosuga M; Okuyama T
Mol Genet Metab Rep; 2016 Jun; 7():87-91. PubMed ID: 27331006
[TBL] [Abstract][Full Text] [Related]
52. Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.
Wang RY; Aminian A; McEntee MF; Kan SH; Simonaro CM; Lamanna WC; Lawrence R; Ellinwood NM; Guerra C; Le SQ; Dickson PI; Esko JD
Mol Genet Metab; 2014 Aug; 112(4):286-93. PubMed ID: 24951454
[TBL] [Abstract][Full Text] [Related]
53. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
54. Dermatan 4-O-sulfotransferase 1 is pivotal in the formation of iduronic acid blocks in dermatan sulfate.
Pacheco B; Maccarana M; Malmström A
Glycobiology; 2009 Nov; 19(11):1197-203. PubMed ID: 19661164
[TBL] [Abstract][Full Text] [Related]
55. Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients.
Ashton LJ; Brooks DA; McCourt PA; Muller VJ; Clements PR; Hopwood JJ
Am J Hum Genet; 1992 Apr; 50(4):787-94. PubMed ID: 1550122
[TBL] [Abstract][Full Text] [Related]
56. Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier.
Maccari F; Sorrentino NC; Mantovani V; Galeotti F; Fraldi A; Volpi N
Metab Brain Dis; 2017 Feb; 32(1):203-210. PubMed ID: 27585464
[TBL] [Abstract][Full Text] [Related]
57. Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking α-l-iduronidase.
Holley RJ; Deligny A; Wei W; Watson HA; Niñonuevo MR; Dagälv A; Leary JA; Bigger BW; Kjellén L; Merry CL
J Biol Chem; 2011 Oct; 286(43):37515-24. PubMed ID: 21873421
[TBL] [Abstract][Full Text] [Related]
58. Biosynthesis of dermatan sulfate. II. Substrate specificity of the C-5 uronosyl epimerase.
Malmström A
J Biol Chem; 1984 Jan; 259(1):161-5. PubMed ID: 6706927
[TBL] [Abstract][Full Text] [Related]
59. Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I.
Peck DS; Lacey JM; White AL; Pino G; Studinski AL; Fisher R; Ahmad A; Spencer L; Viall S; Shallow N; Siemon A; Hamm JA; Murray BK; Jones KL; Gavrilov D; Oglesbee D; Raymond K; Matern D; Rinaldo P; Tortorelli S
Int J Neonatal Screen; 2020 Mar; 6(1):10. PubMed ID: 33073008
[TBL] [Abstract][Full Text] [Related]
60. Partial characterization of heparan and dermatan sulfate proteoglycans synthesized by normal rat glomeruli.
Klein DJ; Brown DM; Oegema TR
J Biol Chem; 1986 Dec; 261(35):16636-52. PubMed ID: 2946688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
